Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07398404 · ClinicalTrials.gov registry record · Phase 1
A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
A Phase 1 study, sponsored by Medical University of South Carolina.
- Not yet
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
NCT07398404 is a Phase 1 study that has not yet begun recruiting, run by Medical University of South Carolina. The registered enrollment target is 64 participants.
The verdict
NCT07398404, a Phase 1 study, has not yet begun recruiting, sponsored by Medical University of South Carolina.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery. The intervention will be compared to a standard of care control group.
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy
- DRUG Bupropion Hydrochloride Extended-release
- DRUG Naltrexone hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2031-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07398404
The ClinicalTrials.gov registry entry for NCT07398404 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cognitive-Behavioral Therapy is the first listed.
NCT07398404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07398404 about?
NCT07398404 is a clinical study titled "A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients". The purpose of this research study is to evaluate a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery. The intervention will be compared to a standard of care control g...
What is the current status of trial NCT07398404?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2026-09-01. Estimated completion is 2031-06-30.
What interventions are being tested in trial NCT07398404?
The interventions under investigation include: Cognitive-Behavioral Therapy (BEHAVIORAL), Bupropion Hydrochloride Extended-release (DRUG), Naltrexone hydrochloride (DRUG).
Who is sponsoring clinical trial NCT07398404?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.